BioDech

Securities class actions are on the rise and life sciences organizations are of specific interest to regulators. In our sixth episode of BioDech, a global life sciences broadcast series,  Joni Jacobsen , co-chair of the global securities and complex litigation team and Angela Liu , securities litigation partner are joined by Tiffany Engsell , Senior Counsel, Litigation & Government Investigati...

Executive compensation plays a critical role in preparing for a successful IPO. In the fifth episode of BioDech, a global life sciences broadcast series, Kevin Kay , partner in Dechert's Employee Benefits and Executive Compensation practice, is joined by guest speakers John Schultz, Managing Director and co-head of the Compensation and Benefits practice at Alvarez & Marsal, and Brennan Ri...

Cybersecurity is the number one topic that keeps boards and executives up at night. Threats of all kinds – from nation states to organized crime – are eager to steal the most valuable information and hold your company ransom, among other cyber threats.  In our fourth episode of BioDech, Brenda Sharton , partner and Chair of Dechert’s top ranked, global Privacy & Cybersecurity practice, and Sop...

In the third episode of BioDech,  a global life sciences broadcast series, Jolie Siegel, Chief Legal Officer of C4 Therapeutics, Inc. , and Marco Taglietti, M.D., Independent Board Director of Aquestive Therapeutics , join Dechert's John Alessi and Stephen Leitzell to discuss corporate governance considerations leading up to an IPO, including board composition, financial controls and overall...

In our second episode of BioDech,  a global life sciences broadcast series, David Rosenthal , corporate and securities partner and co-lead of the firm's life sciences practice, is joined by guest speakers Gregg Beloff , co-founder and managing director of Danforth Advisors, Gabe Cavazos, senior managing director in investment banking at SVB Securities, and Mark Hahn , CFO of Verona Pharma, to...

As a biotech company, how do you determine when you are ready to go public? Our inaugural episode of BioDech, a global life sciences broadcast series, features guest speaker Philip Ross , global chairman of J.P. Morgan Investment Banking, and Dechert's Anna Tomczyk and Gregory Schernecke , partners in the firm's corporate and life sciences practices.  Learn more.